Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver disease

Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver disease

Saved in:

Bibliographic Details
Main Authors:	Hae Won Yoo, Chan Jin Yang, Jeong-Ju Yoo, Young Chang, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Gab Jin Cheon, Young Seok Kim, Hong Soo Kim, Sang Gyune Kim
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136292/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection.
by: Baek Gyu Jun, et al.
Published: (2020-01-01)

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
by: Tom Ryu, et al.
Published: (2025-04-01)

Current Trends and Impact of Liver Biopsy on Survival in Hepatocellular Carcinoma: A Korean Multicenter Analysis
by: Seong Joon Chun, et al.
Published: (2025-03-01)

Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review
by: Hye-Jin Yoo, et al.
Published: (2024-10-01)

Reply to: “Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort””
by: Jisoo Lee, et al.
Published: (2025-05-01)

Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
by: Seung-Kang Yoo, et al.
Published: (2025-03-01)

Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review
by: Hyuk Kim, et al.
Published: (2024-08-01)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
by: Jung Hee Kim, et al.
Published: (2025-12-01)

Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index
by: Sei Kim, et al.
Published: (2025-03-01)

Diagnostic Usefulness of Real-Time Elastography for Liver Fibrosis in Chronic Viral Hepatitis B and C
by: Young Woon Kim, et al.
Published: (2014-01-01)

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
by: Hye Won Lee, et al.
Published: (2025-07-01)

Korea’s 2024 reduction in medical research output amid physician residents’ resignation
by: Jeong-Ju Yoo, et al.
Published: (2025-04-01)

Inhibitory effect of traditional Korean medicine on the recurrent endometriosis after laparoscopic excision: a case report
by: Hae-Won Kim, et al.
Published: (2018-09-01)

Vitamin D supplementation ameliorates ductular reaction, liver inflammation and fibrosis in mice by upregulating TXNIP in ductular cells
by: Eun Bok Baek, et al.
Published: (2025-05-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Gi-Ae Kim, et al.
Published: (2025-01-01)

Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
by: Yeshong Park, et al.
Published: (2024-12-01)

Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
by: Jung Gil Park, et al.
Published: (2020-11-01)

Association of antinuclear antibody positivity with liver disease severity in pediatric metabolic dysfunction-associated steatotic liver disease
by: Hyun Jin Kim, et al.
Published: (2025-02-01)

Association Between Liver Fibrosis and Physical Activity with Bone Mineral Density in Korean Adults
by: Jiho Shin, et al.
Published: (2025-02-01)

Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis
by: Hongsik Lee, et al.
Published: (2015-04-01)

Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial
by: Do Seon Song, et al.
Published: (2025-01-01)

Deep learning-based method for grading histopathological liver fibrosis in rodent models of metabolic dysfunction-associated steatohepatitis
by: Soo Min Ko, et al.
Published: (2025-07-01)

A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
by: Byung-Kwan Jeong, et al.
Published: (2024-08-01)

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review
by: Sae Kyung Joo, et al.
Published: (2024-04-01)

Increased Mesohippocampal Dopaminergic Activity and Improved Depression-Like Behaviors in Maternally Separated Rats Following Repeated Fasting/Refeeding Cycles
by: Jeong Won Jahng, et al.
Published: (2012-01-01)

Comparing non-alcoholic fatty liver disease indices in predicting the prevalence and incidence of metabolic syndrome in middle-aged adults
by: Byung Sik Kim, et al.
Published: (2025-03-01)

Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01)

PM2.5 Exposure in the Respiratory System Induces Distinct Inflammatory Signaling in the Lung and the Liver of Mice
by: Soi Jeong, et al.
Published: (2019-01-01)

Addressing glycan and hematological barriers in pig-to-nonhuman primate liver xenotransplantation: challenges and future directions
by: Jae Young Kim
Published: (2025-03-01)

Outcomes and risk factors for de novo major depressive disorder after liver transplantation: Nested case-control study
by: Young Jin Yoo, et al.
Published: (2025-01-01)

Association between E/e´ ratio and fluid overload in patients with predialysis chronic kidney disease.
by: Jae-Seok Kim, et al.
Published: (2017-01-01)

Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
by: Xiao Liu, et al.
Published: (2024-11-01)

Formulation and Bioequivalence Evaluation of a Miniaturized Fexofenadine Hydrochloride Tablet
by: Woo-Yul Song, et al.
Published: (2025-06-01)

Inhibitory Effect of Loranthus parasiticus on IgE-Mediated Allergic Responses in RBL-2H3 Cells
by: Jae-Myung Yoo, et al.
Published: (2016-01-01)

Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease
by: Hye Young Jin, et al.
Published: (2024-11-01)

Clusterin inhibits lipopolysaccharide induced liver injury
by: Hye-Young Seo, et al.
Published: (2025-02-01)

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
by: Soon Kyu Lee, et al.
Published: (2025-01-01)

Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis
by: Jae Yeon Kim, et al.
Published: (2025-07-01)

Electroacupuncture at neurogenic spots relieves hepatic damage on cholestasis-induced liver injury model
by: Yoo Jung Yi, et al.
Published: (2020-01-01)